Citius Oncology (CTOR) Share-based Compensation Growth (1y) (2024 - 2026)

Citius Oncology (CTOR) Share-based Compensation Growth (1y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 26.47%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 47.06%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.60%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -133.31%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 8.33%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 40.00%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 59.27%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 48.29%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -24.33%
10 Citius Oncology 71.02 Mn 68.39 Mn 1.34 Mn 68.86%

Historic Data

Download Data
DateValue
Mar 31, 2026 68.86%
Dec 31, 2025 118.75%
Jun 30, 2025 8.60%
Mar 31, 2025 -46.09%
Dec 31, 2024 -5.66%